A new AI music generation model called Udio was released this week. It is a notable improvement from previous models of this kind. I recommend this

Compute Thresholds are Ineffective - by Dean W. Ball

submited by

Style Pass

2024-04-18 17:00:05

A new AI music generation model called Udio was released this week. It is a notable improvement from previous models of this kind. I recommend this one in particular.

Researchers have enhanced DeepMind’s AlphaGeometry system with a geometric theorem-proving algorithm called Wu’s Method. DeepMind’s original AlphaGeometry paper, released in January of this year, scored 25/30 on the International Mathematical Olympiad, just short of human gold medalists in this competition for the world’s best high school math students. With Wu’s Method, the system scores 27/30, the first time an AI system has bested human gold medalists.

Apple unveiled a model called Ferret-UI, which is a multimodal language model intended to understand smartphone user interface screens (I wonder what the application could be). Apple has been releasing a lot of interesting research in recent months, almost all of which points to their efforts to make AI assistants run locally on smartphones, laptops, and VR headsets. This has substantial implications for energy use (no data center required), privacy (no need to send prompts to a third-party provider), and policy (many proposed regulatory schemes would effectively require AI developers to monitor their users’ activity and preserve the ability to shut it down, which would probably be impossible, or at least much thornier, if the model was running locally). Local AI can only be so powerful compared to the frontier models, so they are also rumored to be considering a partnership with Google to use Gemini.

Not AI, but it is apparently now possible to arrest tooth decay, perhaps permanently, using a CRISPR-modified bacteria. It’s being marketed as Lumina and available for purchase. Because it’s marketed as a probiotic supplement, it is subject to far less FDA scrutiny than a typical therapeutic. With CRISPR genome editing of bacteria (and soon, creation from scratch of novel forms of bacteria using AI) becoming more common, I wonder how long the FDA will allow this dynamic to persist.